Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
J Am Acad Dermatol. 2021 Aug;85(2):369-378. doi: 10.1016/j.jaad.2020.12.089. Epub 2021 Jan 20.
J Am Acad Dermatol. 2021.
PMID: 33484766
Free article.
Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa.
Tzanetakou V, Stergianou D, Giamarellos-Bourboulis EJ.
Tzanetakou V, et al. Among authors: stergianou d.
Expert Opin Drug Saf. 2020 Apr;19(4):381-393. doi: 10.1080/14740338.2020.1734560. Epub 2020 Feb 28.
Expert Opin Drug Saf. 2020.
PMID: 32098513
Review.
Item in Clipboard
Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab.
Stergianou D, Tzanetakou V, Argyropoulou M, Kanni T, Bagos PG, Giamarellos-Bourboulis EJ.
Stergianou D, et al.
Dermatology. 2021;237(3):372-377. doi: 10.1159/000512617. Epub 2021 Jan 5.
Dermatology. 2021.
PMID: 33401280
Item in Clipboard
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH.
van Straalen KR, et al. Among authors: stergianou d.
Dermatology. 2023;239(3):362-367. doi: 10.1159/000528968. Epub 2023 Jan 30.
Dermatology. 2023.
PMID: 36630943
Free article.
Item in Clipboard
Immune Classification of Hidradenitis Suppurativa: Modulation by Secukinumab.
Stergianou D, Micha S, Tzanetakou V, Kanni T, Gkavogianni T, Katoulis A, Giamarellos-Bourboulis EJ.
Stergianou D, et al.
J Invest Dermatol. 2023 Dec;143(12):2518-2520.e3. doi: 10.1016/j.jid.2023.04.028. Epub 2023 May 19.
J Invest Dermatol. 2023.
PMID: 37211202
No abstract available.
Item in Clipboard
Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa.
Argyropoulou M, Trigoni A, Kaffenberger J, Stergianou D, Damoraki G, Mingiani E, Micha S, Krispinsky A, Meltzanidou P, Kanni T, Lazaridou E, Giamarellos-Bourboulis EJ.
Argyropoulou M, et al. Among authors: stergianou d.
Dermatology. 2023;239(5):746-752. doi: 10.1159/000531558. Epub 2023 Jun 16.
Dermatology. 2023.
PMID: 37331331
Free article.
Item in Clipboard
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa.
Stergianou D, Kanni T, Damoulari C, Giamarellos-Bourboulis EJ.
Stergianou D, et al.
Expert Opin Biol Ther. 2024 Apr;24(4):225-232. doi: 10.1080/14712598.2024.2343112. Epub 2024 Apr 15.
Expert Opin Biol Ther. 2024.
PMID: 38602836
Review.
Item in Clipboard
Cite
Cite